Clinical Trial Update: Validation of a Molecular Prognostic Test for Eye Melanoma

View source ↗

Summary

A clinical trial validating a molecular prognostic test for eye melanoma has been withdrawn. The sponsor is Washington University School of Medicine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Choroidal Neoplasms
• Iris Melanoma
• Uveal Melanoma

Snippet

Sponsor: Washington University School of Medicine | Conditions: Uveal Neoplasms, Choroid Neoplasms | Status: WITHDRAWN